Dr. Matt Kaeberlein, a Professor at the University of Washington School of Medicine, answers questions from a recent webinar that focused on translational geroscience, the drug rapamycin to target biological aging, and the Dog Aging Project.
During this webinar, Dr. Matt Kaeberlein provides an overview of translational geroscience, which he believes will become the paradigm for the practice of medicine in the 21st century. He also discusses his recent work with one such intervention, the drug rapamycin, and its potential to enhance healthspan in companion dogs and people.
Register for the 36th Annual Academy of Surgical Research Virtual Meeting to join surgical research professionals around the world in a two-day exploration of surgical techniques, research applications, technology advancements and industry trends.
Experts present key considerations in the design of rigorous preclinical studies in rodent models of muscular dystrophy, including animal model selection, assays and endpoints, and how your results can inform translation to the clinic.
Experts discuss the use of a novel movement responsive rodent caging system as a means to minimize animal stress and enable unique discovery in many research applications, namely neuroscience, animal behaviour, drug discovery and cardiometabolic disease.